Alexandra Brocato

Alexandra Brocato is an accomplished investment professional with extensive experience in healthcare and technology sectors. Currently serving as an Investment Professional at General Atlantic since May 2022 and previously as a Summer Analyst for the Healthcare & Life Sciences Teams, Alexandra also holds a fellowship with Birthright Israel Excel. Alexandra has held significant roles in various organizations, including Chief Executive Officer at Simplex Sciences Inc., a biotechnology startup associated with Yale University, and as an Investment Analyst at both Toyota Ventures and OurCrowd. Notably, Alexandra co-founded multiple ventures, such as ADVANCE, an AI-driven nursing communication tool, and Sweet, an online event planning platform. An alumnus of Yale University with a combined BS/MS in Biomedical/Medical Engineering, Alexandra broadened international experience as an exchange student at Università Bocconi.